Tamsulosin: all 154 studies that test it

Page 2 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.

• Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic MicrosurgeryStatus unknownNCT03314025Phase 2
• Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia PatientsCompletedNCT03246880Phase 3
• Trial of Tadalafil, Tamsulosin and Combination for Access Sheath DeploymentCompletedNCT03229889Phase 4
• Hernia Surgery Urinary RetentionStatus unknownNCT03027115Phase 4
• Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPHCompletedNCT02972268Phase 3
• Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia RepairCompletedNCT02958878Phase 4
• The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile DysfunctionStatus unknownNCT02862483Phase 3
• PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male VolunteersCompletedNCT02715401Phase 1
• Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male VolunteersCompletedNCT02712411Phase 1
• EC905 Pharmacokinetic Profile StudyCompletedNCT02634489Phase 1
• Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male VolunteersCompletedNCT02529800Phase 1
• Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric PopulationWithdrawnNCT02483793Not applicable
• Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and ProgressionStatus unknownNCT02443844Phase 4
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPHCompletedNCT02390882Phase 3
• Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTSCompletedNCT02303769Phase 3
• Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male VolunteersCompletedNCT02266537Phase 1
• Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding DisordersCompletedNCT02266524Phase 1
• Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male SubjectsCompletedNCT02266511Phase 1
• Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male VolunteersCompletedNCT02264184Phase 1
• CKD-397 Drug-drug Interaction Study (A)CompletedNCT02247518Phase 1
• CKD-397 Drug-drug Interaction Study (B)CompletedNCT02247505Phase 1
• FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)CompletedNCT02244294Phase 2
• Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding SymptomsCompletedNCT02244281Phase 2
• FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244255Phase 4
• Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244242Phase 4
• Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) PatientsCompletedNCT02244229Phase 4
• Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and TamsulosinCompletedNCT02239484Phase 1
• Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and TamsulosinCompletedNCT02180997Phase 1
• Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male SubjectsCompletedNCT02169713Phase 1
• A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy SubjectsCompletedNCT02138773Phase 1
• Ureteral Stent-related Pain and Mirabegron (SPAM) TrialCompletedNCT02095665Phase 4
• A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male VolunteersCompletedNCT02072213Phase 1
• The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic HyperplasiaStatus unknownNCT02033798Not applicable
• This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood SamplesCompletedNCT01957189Phase 1
• A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and TamsulosinCompletedNCT01953887Phase 1
• Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent SymptomsCompletedNCT01880619Phase 4
• Tamsulosin for Urinary Retention in Hospitalized Older WomenTerminatedNCT01747993Phase 3
• Bioequivalence - Duodart Against Avodart & OmnicCompletedNCT01657851Phase 1
• Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave LithotripsyWithdrawnNCT01560091Phase 3
• A Study to Evaluate Cardiovascular Interactions Between Mirabegron and TamsulosinCompletedNCT01489696Phase 1
• Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)Status unknownNCT01404637Not applicable
• Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal CalculusStatus unknownNCT01215708Phase 3
• Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical ProstatectomyStatus unknownNCT01209988Not applicable
• Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting ConditionsCompletedNCT01149746Phase 1
• Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and TamsulosinCompletedNCT01100021Phase 1
• Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary CalculusStatus unknownNCT01010048Phase 4
• Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mgStatus unknownNCT00954889Not applicable
• Prevention of Acute Voiding Difficulty After Radical ProctectomyCompletedNCT00606983Phase 3
• Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding DysfunctionStatus unknownNCT00602186Phase 1/2
• The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department PatientsCompletedNCT00600405Not applicable
• A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPHCompletedNCT00510406Phase 2
• Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With TamsulosinStatus unknownNCT00478998Phase 2
• Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
• Evaluation of Tamsulosin in the Treatment of Ureteral StonesCompletedNCT00151567Phase 3

← Tamsulosin overview